Jianlei Yuan

People's Hospital of Cangzhou

Papers

2

Total Citations

89

H-Index

2

About

Dr. Jianlei Yuan is a leading surgical oncologist whose research centers on advancing pancreatic surgery through minimally invasive techniques, particularly robotic pancreaticoduodenectomy (RPD). His major contributions lie in providing robust, multicenter evidence comparing RPD to traditional open pancreaticoduodenectomy (OPD), addressing critical gaps in surgical decision-making. His landmark 2021 study, cited 75 times, demonstrated that RPD achieves comparable perioperative and oncological outcomes to OPD in low-risk surgical candidates, challenging long-held assumptions about the superiority of open approaches. Dr. Yuan further extended this work to vulnerable populations, showing in a 2022 multicenter study (14 citations) that elderly patients also benefit from RPD without increased complications. These findings have helped establish robotic surgery as a safe, effective alternative for pancreaticoduodenectomy, potentially expanding access to less invasive treatment. His rigorous comparative effectiveness research, combining large sample sizes with careful patient stratification, has influenced clinical guidelines and surgical practice worldwide. Dr. Yuan’s work continues to shape the future of pancreatic cancer surgery, making him a pivotal figure in the transition toward robotic-assisted procedures.

Research Focus

Key Achievements

2
H-Index
2
Papers
89
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates
75 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: People's Hospital of Cangzhou

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago